Wene Wei
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Heat shock proteins research
- Extracellular vesicles in disease
Papers in
-
- Circular RNAs in diseases 3
- Heat shock proteins research 3
- Extracellular vesicles in disease 3
- RNA modifications and cancer 3
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 6
- Co-authors
- Shufang Ning (14 shared papers)Litu Zhang (14 shared papers)Jilin Li (10 shared papers)Haizhou Liu (10 shared papers)Jian‐Hong Zhong (4 shared papers)Jiansi Chen (3 shared papers)Xianwei Mo (3 shared papers)Kaisheng Liu (2 shared papers)
- Journals
- Frontiers in Cell and Developmental Biology (2 papers)Frontiers in Molecular Biosciences (2 papers)Oncology Reports (1 paper)Cell Death and Disease (1 paper)Frontiers in Bioengineering and Biotechnology (1 paper)
- Partner nations
- ChinaTajikistan
In The Last Decade
Wene Wei
19 papers receiving 399 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 207
- Molecular Biology 263
- Oncology 85
- Pulmonary and Respiratory Medicine 69
- Hepatology 11
Countries citing papers authored by Wene Wei
This map shows the geographic impact of Wene Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wene Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wene Wei more than expected).
Fields of papers citing papers by Wene Wei
This network shows the impact of papers produced by Wene Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wene Wei. The network helps show where Wene Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Wene Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 81 | |
| 2 | 2021 | 51 | |
| 3 | 2019 | 46 | |
| 4 | 2019 | 41 | |
| 5 | 2020 | 31 | |
| 6 | 2016 | 28 | |
| 7 | 2021 | 27 | |
| 8 | 2016 | 17 | |
| 9 | 2016 | 15 | |
| 10 | 2015 | 11 | |
| 11 | 2022 | 11 | |
| 12 | 2021 | 11 | |
| 13 | 2023 | 10 | |
| 14 | 2021 | 8 | |
| 15 | Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features. | 2014 | 6 |
| 16 | 2023 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2025 | 3 | |
| 19 | 2023 | 2 |
About Wene Wei
Wene Wei is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 19 papers that have together received 405 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (3 papers), Heat shock proteins research (3 papers), Extracellular vesicles in disease (3 papers), RNA modifications and cancer (3 papers), Lung Cancer Research Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Cancer Research (207 citations), Molecular Biology (263 citations), Oncology (85 citations), Pulmonary and Respiratory Medicine (69 citations) and Hepatology (11 citations). Wene Wei has collaborated with scholars based in China and Tajikistan. Frequent co-authors include Shufang Ning, Litu Zhang, Jilin Li, Haizhou Liu, Jian‐Hong Zhong, Jiansi Chen, Xianwei Mo, Kaisheng Liu, Yuxuan Xie and Aifang Yang. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Frontiers in Molecular Biosciences, Oncology Reports, Cell Death and Disease and Frontiers in Bioengineering and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.